The Diflunisal Tablets, cataloged under National Stock Number 6505-01-164-0581, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Merck Sharp & Dohme Corp. Dba Merck Div Us Human Health. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-164-0581 |
| Primary Part Number | NDC00006-0675-61 |
| Item Name | Diflunisal Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Merck Sharp & Dohme Corp. Dba Merck Div Us Human Health |
| Status | ACTIVE |
| Primary Container Content Quantity | 60.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 250.000 MILLIGRAMS DIFLUNISAL ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC60951-0756-60 | Endo Pharmaceuticals Inc Dba Endo Pharmaceuticals Holdings Inc (USA) |
| NDC00006-0675-61 PRIMARY | Merck Sharp & Dohme Corp. Dba Merck Div Us Human Health (USA) |
| Reference | Meaning |
|---|---|
| DOLOBID | 5/1 Secondary reference Merck Sharp & Dohme Corp. Dba Merck Div Us Human Health |
| DOLOBID TABLETS | 5/1 Secondary reference Merck Sharp & Dohme Corp. Dba Merck Div Us Human Health |
NSN 6505-01-164-0581 is a Diflunisal Tablets, manufactured by Merck Sharp & Dohme Corp. Dba Merck Div Us Human Health, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-164-0581 has 2 manufacturer part numbers on file: NDC60951-0756-60 (Endo Pharmaceuticals Inc Dba Endo Pharmaceuticals Holdings Inc), NDC00006-0675-61 (Merck Sharp & Dohme Corp. Dba Merck Div Us Human Health).
Key specifications for NDC00006-0675-61: Primary Container Content Quantity: 60.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Part Name Assigned by Controlling Agency: DIFLUNISAL TABLETS USP 250MG 60S BT. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.